Pathway of Toll-Like receptor 7/B cell activating factor/B cell activating factor receptor plays a role in immune thrombocytopenia in vivo

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Yang, Qing ^a,b   Xu, Shuqian ^b   Li, Xiaofang ^c   Wang, Bo ^b   Wang, Xuping ^b   Ma, Daoxin ^b   Yang, Lei ^b   Peng, Jun ^b   Hou, Ming ^b  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; IMMUNOGLOBULIN G; LENTIVIRUS VECTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR AGONIST; MEMBRANE PROTEIN; TLR7 PROTEIN, MOUSE; TNFSF13B PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL DESTRUCTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; IMMUNE THROMBOCYTOPENIA; IN VIVO STUDY; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RECEPTOR UPREGULATION; SPLEEN CELL; THROMBOCYTE COUNT; ANIMAL; BLOOD; FEMALE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; LENTIVIRINAE; METABOLISM; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA;

LENTIVIRUS; MUS;

ANIMALS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; FEMALE; FLOW CYTOMETRY; GENE SILENCING; IMMUNOGLOBULIN G; LENTIVIRUS; MEMBRANE GLYCOPROTEINS; MICE; PLATELET COUNT; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA; TOLL-LIKE RECEPTOR 7;

EID: 79960784716     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022708     Document Type: Article

References (33)

1. Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, et al. (2008) Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost 99: 4-13.
2. Moransard M, Sawitzky M, Fontana A, Suter T, (2010) Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis. Glia 58: 559-571.
3. Khan S, Greenberg JD, Bhardwaj N, (2009) Dendritic cells as targets for therapy in rheumatoid arthritis. Nat Rev Rheumatol 5: 566-571.
4. Catani L, Fagioli ME, Tazzari PL, Ricci F, Curti A, et al. (2006) Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes. Exp Hematol 34: 879-887.
5. Kuwana M, Okazaki Y, Ikeda Y, (2009) Splenic macrophages maintain the anti-platelet autoimmune responses via uptake of opsonized platelets in patients with immune thrombocytopenic purpura. J Thromb Haemost 7: 322-329.
6. Takeda K, Kaisho T, Akira S, (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376.
7. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
8. Li M, Zhou Y, Feng G, Su SB, (2009) The critical role of toll-like receptor signaling pathways in the induction and progression of autoimmune disease. Curr Mol Med 9: 365-374.
9. Savarese E, Steinberg C, Pawar RD, Reindl W, Akira S, et al. (2008) Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum 58: 1107-1115.
10. Sood R, Wong W, Jeng M, Zehnder JL, (2006) Gene expression profile of idiopathic thrombocytopenic purpura (ITP). Pediatr Blood Cancer 47: 675-677.
11. Rolink AG, Tschopp J, Schneider P, Melchers F, (2002) BAFF is a survival and maturation factor for mouse B cells. Eur J Immunol 32: 2004-2010.
12. Zhang J, Roschke V, Baker KP, Wang Z, Alarcón GS, et al. (2001) Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166: 6-10.
13. Thangarajh M, Gomes A, Masterman T, Hillert J, Hjelmström P, (2004) Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis. J Neuroimmunol 152: 183-190.
14. Matsushita T, Hasegawa M, Yanaba K, Kodera M, Takehara K, et al. (2006) Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes. Arthritis Rheum 54: 192-201.
15. Nakajima K, Itoh K, Nagatani K, Okawa-Takatsuji M, Fujii T, et al. (2007) Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis. Scand J Rheumatol 36: 365-372.
16. Kato A, Truong-Tran AQ, Scott AL, Matsumoto K, Schleimer RP, (2006) Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism. J Immunol 177: 7164-7172.
17. Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kmbayashi T, et al. (2007) TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol 178: 7531-7539.
18. Musaji A, Vanhoorelbeke K, Deckmyn H, Coutelier JP, (2004) New model of transient strain-dependent autoimmune thrombocytopenia in mice immunized with rat platelets. Exp Hematol 32: 87-94.
19. Santiago-Raber ML, Baudino L, lzui S, (2009) Emerging roles of TLR7 and TLR9 in murine SLE. J Autoimmun 33: 231-238.
20. Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, et al. (2007) Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol 18: 1721-1731.
21. Moon EY, Lee JH, Oh SY, Ryu SK, Kim HM, et al. (2006) Reactive oxygen species augment B-cell-activating factor expression. Free Radic Biol Med 40: 2103-2111.
22. Alsaleh G, Messer L, Semaan N, Boulanger N, Gottenberg JE, et al. (2007) BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligand. Arthritis Rheum 56: 3202-3214.
23. Treml JF, Hao Y, Stadanlick JE, Cancro MP, (2009) The BLyS family: toward a molecular understanding of B cell homeostasis. Cell Biochem Biophys 53: 1-16.
24. Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, et al. (2009) B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci USA 106: 13945-13950.
25. Carter RH, Zhao H, Liu X, Pelletier M, Chatham W, et al. (2005) Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus. Arthritis Rheum 52: 3943-3954.
26. Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, et al. (2007) Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis 66: 790-797.
27. Thangarajh M, Kisiswa L, Pirskanen R, Hillert J, (2007) The expression of BAFF-binding receptors is not altered in multiple sclerosis or myasthenia gravis. Scand J Immunol 65: 461-466.
28. Zhou Z, Chen Z, Li H, Chen X, Xu J, et al. (2009) BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura. Autoimmunity 42: 112-119.
29. Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, et al. (2007) BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 204: 1959-1971.
30. Al-Salleeh F, Petro TM, (2007) TLR3 and TLR7 are invovled in expression of IL-23 subunits while TLR3 but not TLR7 is involved in expression of IFN-beta by Theiler's virus-infected RAW264.7 cells. Microbes Infect 9: 1384-1392.
31. Shi CY, Wang R, Liu CX, Jiang H, Ma ZY, et al. (2009) Simvastatin inhibits acidic extracellular pH-activated, outward rectifying chloride currents in RAW264.7 monocytic-macrophage and human peripheral monocytes. Int Immunopharmacol 9: 247-252.
32. Pawar RD, Patole PS, Zecher D, Segerer S, Kretzler M, et al. (2006) Toll-like receptor-7 modulates immune complex glomerulonephritis. J Am Soc Nephrol 17: 141-149.
33. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods 25: 402-408.